Avanos Medical

AVNS47

$24.03arrow_drop_up0.12%$0.03

AVNS47

$24.03

arrow_drop_up0.12%$0.03

Performance History

Key Stats
Open	$23.78
Prev. Close	$23.54
EPS	0.15
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

	LOW	HIGH
Day Range	23.53	24.06
52 Week Range	17.23	24.77

Ratios







EPS	0.15

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Avanos Medical (AVNS)

Avanos Medical Inc (AVNS) is a company that specializes in medical products and solutions. With a history dating back several decades, Avanos has grown to become a leader in the healthcare industry. The company's focus is on developing and manufacturing innovative medical devices that improve patient outcomes and enhance healthcare delivery. Avanos's product portfolio includes a wide range of solutions for various medical specialties, including pain management, respiratory care, and gastrointestinal health.

The stock price history of Avanos Medical Inc (AVNS) shows a steady upward trend over the years. While there have been occasional dips, the overall trajectory has been positive. Investors who bought Avanos stock in the past have seen their investment grow significantly. With the increasing demand for healthcare solutions, Avanos is well-positioned to continue its growth in the future.

Websitecall_made

Sector: Healthcare
Industry: Medical Devices
CEO: Mr. Joseph F. Woody
Headquarters: Alpharetta
Employees: 4044
Exchange: NYSE

Keep an eye on Avanos Medical

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Avanos Medical 's (AVNS) price per share?

The current price per share for Avanos Medical (AVNS) is $24.03. The stock has seen a price change of $0.03 recently, indicating a 0.12% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Avanos Medical (AVNS)?

For Avanos Medical (AVNS), the 52-week high is $24.77, which is 3.08% from the current price. The 52-week low is $17.24, the current price is 39.43% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Avanos Medical (AVNS) a growth stock?

Avanos Medical (AVNS) has shown an average price growth of 0.41% over the past three years. It has received a score of 23 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Avanos Medical as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Avanos Medical (AVNS) stock price performance year to date (YTD)?

As of the latest data, Avanos Medical (AVNS) has a year-to-date price change of 5.95%. Over the past month, the stock has experienced a price change of 4.12%. Over the last three months, the change has been 26.87%. Over the past six months, the figure is 25.88%. Looking at a longer horizon, the five-year price change stands at -37%.

help

Is Avanos Medical (AVNS) a profitable company?

Avanos Medical (AVNS) has a net income of -$9.9M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 56.84% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 6.81% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $673.3M, although specific revenue growth data is currently not available. The gross profit is $382.7M. Operating income is noted at $52.4M. Furthermore, the EBITDA is $73.4M.

help

What is the market capitalization of Avanos Medical (AVNS)?

Avanos Medical (AVNS) has a market capitalization of $1.1B. The average daily trading volume is 190.64K, indicating the stock's liquidity and investor engagement.